EP 3442500 A1 20190220 - USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES
Title (en)
USE OF FENOFIBRIC ACID IN THE TREATMENT OF HEPATIC DISEASES
Title (de)
VERWENDUNG VON FENOFIBRINSÄURE ZUR BEHANDLUNG VON HEPATISCHEN ERKRANKUNGEN
Title (fr)
UTILISATION DE L'ACIDE FENOFIBRIQUE DANS LE TRAITEMENT DES MALADIES HEPATIQUES
Publication
Application
Priority
- FR 1653378 A 20160415
- EP 2017059025 W 20170413
Abstract (en)
[origin: WO2017178630A1] The invention relates to a composition comprising, as the sole active ingredient, fenofibric acid or one of the pharmaceutically acceptable salts thereof, said composition being intended for use in the treatment of hepatic diseases. The field of the invention is that involving the treatment and prevention of hepatic diseases, such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatic fibrosis or cirrhosis.
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61P 1/16 (2006.01)
CPC (source: EP US)
A61K 9/0007 (2013.01 - US); A61K 9/0019 (2013.01 - US); A61K 9/0056 (2013.01 - US); A61K 9/006 (2013.01 - US); A61K 9/2054 (2013.01 - EP US); A61K 31/192 (2013.01 - EP US); A61P 1/16 (2017.12 - EP US)
Citation (search report)
See references of WO 2017178630A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017178630 A1 20171019; EP 3442500 A1 20190220; FR 3050112 A1 20171020; FR 3050112 B1 20200904; US 2019247343 A1 20190815
DOCDB simple family (application)
EP 2017059025 W 20170413; EP 17717192 A 20170413; FR 1653378 A 20160415; US 201716094183 A 20170413